Herbalife International
April 30, 2026
LOS ANGELES, Calif. -- April 30, 2026
Herbalife said it has acquired substantially all of the assets of Bioniq's core personalized nutrition business, closing the deal contemplated in the agreement announced March 26, 2026.
The company said total base consideration is 55 million dollars, payable over five years, of which 10 million dollars was paid after closing. The agreement also provides for up to 95 million dollars in contingent payments based on future Bioniq product sales. As part of the transaction, Herbalife obtained a call option to acquire Bioniq LAB, a separate platform focused on small molecules and peptides, with the option expiring December 31, 2031.
Herbalife has said the Bioniq assets expand its personalized supplement capabilities. The closing was highlighted in the company's May 6 first-quarter earnings release alongside its debt refinancing.